BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Jeff Collins to sit on the review panel for the Life Science Company Showcase Event at the North Carolina Biotechnology Center in Research Triangle Park, NC
News | 10. 15. 2008
